In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 12, 1996, Pages 933-936

  Garcia, R ^a   Raad, I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAMANDOLE; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DAPTOMYCIN; NOVOBIOCIN; OXACILLIN; QUINUPRISTIN; RIFAMPICIN; STREPTOGRAMIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CEFAMANDOLE; CEPHALOSPORINS; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; NOVOBIOCIN; OXACILLIN; PENICILLINS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TEICOPLANIN; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0030482620     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01690511     Document Type: Article

References (15)

1. Raad II, Bodey GP: Infectious complications of indwelling vascular catheters. Clinical Infectious Diseases 1992, 15: 197-210.
2. Nafziger DJ, Wenzel RP: Coagulase-negative staphylococci. Epidemiology, evaluation, and therapy. Infectious Disease Clinics of North America 1989, 3: 915-929.
3. Farber BF, Kaplan MH, Clogston AG: Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. Journal of Infectious Diseases 1990, 161: 37-40.
4. Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM: Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. Journal of Infectious Diseases 1994, 170: 720-723.
5. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ: Bacterial biofilms in nature and disease. Annual Review of Microbiology 1987, 41: 435-464.
6. Barriere JC, Bouanchaud DH, Paris JM, Robin O, Harris NV, Smith C: Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 1-8.
7. Pechere JC: In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 15-18.
8. Brumfitt W, Hamilton-Miller JMT, Shah S: In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 29-37.
9. Aumercier M, Bouhallab S, Capman ML, Le Goffic F: RP 59500: a proposed mechanism for its bactericidal activity. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 9-14.
10. Leclercq R, Nautas L, Soussy CJ, Duval J: Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 67-75.
11. Chin NX, Neu HC: Post-antibiotic effect of the new streptogramin RP 59500. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 642-645.
12. Etienne SD, Montay G, Le Liboux A, Frydman A, Garaud JJ: A phase I, double blind, placebo-controlled study of the tolerance and pharmacokinetic behavior of RP 59500. Journal of Antimicrobial Chemotherapy 1992, 30, Supplement A: 123-131.
13. Thabaut A, Meyran M, Huerre M: Evolution and present situation of Staphylococcus aureus sensitivity of MLS in hospital (1975-83). Journal of Antimicrobial Chemotherapy 1985, 16, Supplement A: 205-207.
14. Schwalbe RS, Stapleton JT, Gilligan PH: Emergence of vancomycin resistance in coagulase-negative staphylococci. New England Journal of Medicine 1987, 316: 927-931.
15. Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC: In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrobial Agents and Chemotherapy 1993, 37: 598-601.